USC.edu
Are You a Patient?

Jeffrey A Kahn, MD

Professor of Clinical Medicine, Acting Chief, Division of GI and Liver Diseases

Image of Jeffrey A Kahn, MD
Is this your profile? Click to edit
Request an Appointment
Phone +1 323 442 5908
Email [email protected]
CTSI Profile

Overview

Dr. Kahn is the medical director of the USC Liver Transplant Program. He received fellowship training in gastroenterology and transplant hepatology from the Keck School of Medicine and Cedars-Sinai Medical Center. He is board certified in internal medicine, gastroenterology and transplant hepatology.

Dr. Kahn’s primary research interests are in liver transplantation, hepatocellular carcinoma and viral hepatitis. He has written and co-authored several abstracts and peer-reviewed articles on various topics such as chronic hepatitis C and liver transplantation. He is also a distinguished lecturer.

Awards

  • Alpha Omega Alpha, 1990

Publications

  • Liver Transplantation After Prolonged Nab-Sirolimus Therapy for Unresectable Hepatic Perivascular Epithelioid Cell Tumor With Bilobar Involvement. ACG Case Rep J. 2026 Apr; 13(4):e02095.. View in PubMed
  • A pilot randomized controlled trial of a transportation assistance program in liver transplant (TAP-LT) candidates. Liver Transpl. 2026 Aug 01; 32(8):1148-1156.. View in PubMed
  • Alkaline Phosphatase Normalization Occurs Less Frequently in Hispanic Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2026 Jan 29.. View in PubMed
  • High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers. Liver Int. 2025 09; 45(9):e70255.. View in PubMed
  • Comparing donor selection barriers for living donor liver transplantation among Hispanic and non-Hispanic candidates in a large urban center. Liver Transpl. 2025 Dec 01; 31(12):1464-1471.. View in PubMed
  • The University of Southern California psychosocial checklist: A novel tool to remotely screen transplant candidates with alcohol-associated liver disease prior to hospital transfer. Liver Transpl. 2025 Feb 01; 31(2):250-253.. View in PubMed
  • Unresectable Metastatic Solid Pseudopapillary Pancreatic Neoplasm Treated With Liver Transplantation. ACG Case Rep J. 2024 Aug; 11(8):e01432.. View in PubMed
  • Characteristics and Outcomes Among US Commercially Insured Transgender Adults With Cirrhosis: A National Cohort Study. Am J Gastroenterol. 2024 12 01; 119(12):2455-2461.. View in PubMed
  • Benign to Malignant Hepatic Lesion Transformation in Abernethy Malformation. ACG Case Rep J. 2024 Apr; 11(4):e01307.. View in PubMed
  • Low frequency of HBsAg reemergence in liver transplant recipients after stopping hepatitis B immune globulin: Implications for prophylaxis protocols. Liver Transpl. 2024 06 01; 30(6):668-671.. View in PubMed

Similar People